IONIS-DGAT2Rx

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameIONIS-DGAT2Rx
Drug Alias NameISIS-484137IONIS-DGAT2RxION-224ISIS-DGAT2
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionDiacylglycerol O-acyltransferase 2 inhibitors
TargetsDiacylglycerol O-acyltransferase 2
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsFatty Liver

Other Information

ATC CodeN/A
Related LinksN/A